- Revisiting vitamin therapy for HDA research group in Spain is planning a clinical trial to explore if biotin and thiamine supplementation may help treat motor symptoms of Huntington’s Disease. This strategy emerged from their observations that some protein changes in both mice and people with the HD gene mutation resembled those seen in another ... read more
- A spoonful of branaplam helps the huntingtin go downScientists at Novartis and The Children’s Hospital of Philadelphia have recently published a paper detailing how the drug branaplam, originally developed for the neurological disease spinal muscular atrophy (SMA), could be repurposed to treat Huntington’s disease. Branaplam can lower levels of the huntingtin protein and is now being tested in ... read more
- Huntington’s disease therapeutics conference 2022 – Day 3Good morning! Today is the 3rd and final day of the #CHDI HD Therapeutics Conference in Palm Springs. Follow our feed today to get live updates! Biomarkers and clinical toolsThe fourth session of research talks will cover biomarkers and clinical tools for diagnosing, tracking, and treating HD. It is being ... read more
- Huntington’s disease therapeutics conference 2022 – Day 2Good morning and welcome to Day 2 of HDBuzz coverage of the CHDI HD Therapeutics conference!Innovative approaches for HD therapeuticsChairing the third session of HD research talks is Dr. Michael Finley (CHDI) and Dr. William Martin (Janssen R&D, LLC) are chairing the third session of HD research talks, which will ... read more
- Huntington’s disease therapeutics conference 2022 – Day 1Good morning from sunny Palm Springs! After a 2-year hiatus because of COVID, the HD Therapeutics Conference is back in person this year - the biggest annual gathering of HD researchers! Our Twitter updates are compiled below. Continue to follow live updates for the rest of the conference with the ... read more